CBIO vs STE · $491.3M cap vs P/E 25, rev $5.46B
Crescent Biopharma, Inc. (CBIO) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Crescent Biopharma, Inc. (CBIO) is a biotechnology company listed on NASDAQ.
STERIS plc (STE) is a medical devices company listed on NYSE.
CBIO does not have a complete income-statement cache yet.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
CBIO currently screens at market cap $491.3M. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the CBIO and STE stock pages for the full models.
Not investment advice.